Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005268013 | SCV005933167 | uncertain significance | not specified | 2024-12-12 | criteria provided, single submitter | clinical testing | The c.6C>A (p.D2E) alteration is located in exon 1 (coding exon 1) of the SCGN gene. This alteration results from a C to A substitution at nucleotide position 6, causing the aspartic acid (D) at amino acid position 2 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |